She is the Assistant Secretary of the Manufacturing Quality Branch (MQB), TGA. MQB assists in the timely supply of therapeutic goods, ensuring they are of appropriate quality for their entire lifecycle. This primarily relies on assessing manufacturers' compliance with Good Manufacturing Practice for medicines, blood, tissues and cellular therapy products and conducting product recalls for all types of therapeutic goods. MQB also has responsibility for the quality requirements for medicinal cannabis, psilocybin and MDMA products.

Jenny has a science background, working as a chemist in both private industry and government laboratories. After a number of years in the TGA Laboratories Branch, and a stint of living overseas for 3 years, she worked in various TGA pre-market assessment areas in medicine regulation before moving to MQB in 2021.